Regions Financial Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $581K | Buy |
1,300
+191
| +17% | +$89.1K | ﹤0.01% | 573 |
|
|
2025
Q4 | $503K | Buy |
1,109
+462
| +71% | +$199K | ﹤0.01% | 606 |
|
|
2025
Q3 | $253K | Sell |
647
-90
| -12% | -$37.6K | ﹤0.01% | 764 |
|
|
2025
Q2 | $328K | Buy |
737
+30
| +4% | +$13.8K | ﹤0.01% | 690 |
|
|
2025
Q1 | $343K | Buy |
707
+51
| +8% | +$23.8K | ﹤0.01% | 659 |
|
|
2024
Q4 | $264K | Sell |
656
-352
| -35% | -$163K | ﹤0.01% | 727 |
|
|
2024
Q3 | $469K | Sell |
1,008
-16
| -2% | -$7.69K | ﹤0.01% | 603 |
|
|
2024
Q2 | $480K | Buy |
1,024
+270
| +36% | +$117K | ﹤0.01% | 584 |
|
|
2024
Q1 | $315K | Buy |
754
+54
| +8% | +$22.8K | ﹤0.01% | 690 |
|
|
2023
Q4 | $285K | Sell |
700
-565
| -45% | -$209K | ﹤0.01% | 715 |
|
|
2023
Q3 | $440K | Sell |
1,265
-10
| -0.8% | -$3.5K | ﹤0.01% | 589 |
|
|
2023
Q2 | $449K | Sell |
1,275
-28
| -2% | -$9.43K | ﹤0.01% | 603 |
|
|
2023
Q1 | $411K | Sell |
1,303
-62
| -5% | -$18.6K | ﹤0.01% | 634 |
|
|
2022
Q4 | $394K | Sell |
1,365
-2
| -0.1% | -$610 | ﹤0.01% | 638 |
|
|
2022
Q3 | $396K | Sell |
1,367
-392
| -22% | -$113K | ﹤0.01% | 619 |
|
|
2022
Q2 | $495K | Sell |
1,759
-307
| -15% | -$82.2K | ﹤0.01% | 595 |
|
|
2022
Q1 | $539K | Sell |
2,066
-952
| -32% | -$226K | ﹤0.01% | 609 |
|
|
2021
Q4 | $663K | Sell |
3,018
-1,346
| -31% | -$262K | 0.01% | 576 |
|
|
2021
Q3 | $791K | Sell |
4,364
-7,668
| -64% | -$1.5M | 0.01% | 522 |
|
|
2021
Q2 | $2.43M | Sell |
12,032
-53,803
| -82% | -$11.3M | 0.02% | 329 |
|
|
2021
Q1 | $14.1M | Sell |
65,835
-7,951
| -11% | -$1.75M | 0.13% | 136 |
|
|
2020
Q4 | $17.4M | Sell |
73,786
-270
| -0.4% | -$61.9K | 0.17% | 123 |
|
|
2020
Q3 | $20.2M | Buy |
74,056
+5,750
| +8% | +$1.59M | 0.22% | 106 |
|
|
2020
Q2 | $19.8M | Buy |
68,306
+6,911
| +11% | +$1.87M | 0.23% | 105 |
|
|
2020
Q1 | $14.6M | Sell |
61,395
-1,469
| -2% | -$337K | 0.19% | 120 |
|
|
2019
Q4 | $13.8M | Sell |
62,864
-182
| -0.3% | -$36.8K | 0.14% | 138 |
|
|
2019
Q3 | $10.7M | Buy |
63,046
+4,401
| +8% | +$779K | 0.12% | 147 |
|
|
2019
Q2 | $10.8M | Buy |
58,645
+12,672
| +28% | +$2.22M | 0.12% | 144 |
|
|
2019
Q1 | $8.46M | Buy |
45,973
+44,231
| +2,539% | +$8.17M | 0.1% | 157 |
|
|
2018
Q4 | $288K | Sell |
1,742
-2,107
| -55% | -$365K | ﹤0.01% | 652 |
|
|
2018
Q3 | $742K | Sell |
3,849
-1,036
| -21% | -$184K | 0.01% | 471 |
|
|
2018
Q2 | $831K | Sell |
4,885
-2,158
| -31% | -$335K | 0.01% | 457 |
|
|
2018
Q1 | $1.15M | Sell |
7,043
-2,526
| -26% | -$413K | 0.01% | 401 |
|
|
2017
Q4 | $1.43M | Sell |
9,569
-1,778
| -16% | -$263K | 0.02% | 371 |
|
|
2017
Q3 | $1.73M | Sell |
11,347
-4,135
| -27% | -$622K | 0.02% | 326 |
|
|
2017
Q2 | $2M | Sell |
15,482
-76,766
| -83% | -$9.24M | 0.02% | 301 |
|
|
2017
Q1 | $10.1M | Sell |
92,248
-18,664
| -17% | -$1.64M | 0.12% | 139 |
|
|
2016
Q4 | $8.17M | Sell |
110,912
-5,921
| -5% | -$482K | 0.1% | 146 |
|
|
2016
Q3 | $10.2M | Sell |
116,833
-5,351
| -4% | -$506K | 0.13% | 132 |
|
|
2016
Q2 | $10.5M | Buy |
122,184
+5,942
| +5% | +$513K | 0.14% | 132 |
|
|
2016
Q1 | $9.24M | Buy |
116,242
+10,478
| +10% | +$948K | 0.12% | 146 |
|
|
2015
Q4 | $13.3M | Buy |
105,764
+7,030
| +7% | +$849K | 0.18% | 124 |
|
|
2015
Q3 | $10.3M | Buy |
98,734
+10,659
| +12% | +$1.37M | 0.15% | 138 |
|
|
2015
Q2 | $10.9M | Buy |
88,075
+72,950
| +482% | +$9.19M | 0.14% | 143 |
|
|
2015
Q1 | $1.78M | Buy |
15,125
+3,035
| +25% | +$364K | 0.02% | 359 |
|
|
2014
Q4 | $1.44M | Sell |
12,090
-278
| -2% | -$31.3K | 0.02% | 419 |
|
|
2014
Q3 | $1.39M | Sell |
12,368
-1,002
| -7% | -$95.4K | 0.02% | 483 |
|
|
2014
Q2 | $1.27M | Buy |
13,370
+2,986
| +29% | +$209K | 0.02% | 520 |
|
|
2014
Q1 | $734K | Buy |
10,384
+1,111
| +12% | +$88K | 0.01% | 680 |
|
|
2013
Q4 | $689K | Buy |
+9,273
| New | +$646K | 0.01% | 676 |
|
Other funds holding VRTX
VCM
VPM
Regions Financial Corp's VRTX Position: Q1 2026 in Review
Regions Financial Corp increased its Vertex Pharmaceuticals (VRTX) stake by 17% in Q1 2026, buying an estimated $89.1K and bringing the position to 1,300 shares worth $581K. The position accounts for ﹤0.01% of the portfolio, ranked #573.
Regions Financial Corp first reported a position in VRTX in Q4 2013 and has held it in 50 quarters since. The position peaked at $20.2M in Q3 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Regions Financial Corp held 1,300 shares of Vertex Pharmaceuticals worth $581K as of Q1 2026.
- Regions Financial Corp bought 191 Vertex Pharmaceuticals shares in Q1 2026, an estimated $89.1K.
- Vertex Pharmaceuticals made up ﹤0.01% of Regions Financial Corp's portfolio in Q1 2026, its #573 holding.
- Regions Financial Corp first reported a position in Vertex Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
- Regions Financial Corp's Vertex Pharmaceuticals position peaked at $20.2M in Q3 2020.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.